Table of Contents
Advances in Endocrinology
Volume 2015 (2015), Article ID 353121, 6 pages
http://dx.doi.org/10.1155/2015/353121
Research Article

Thyroid Diseases in Omani Type 2 Diabetics: A Retrospective Cross-Sectional Study

1Oman Medical Specialty Board (OMSB), P.O. Box 745, 121 Seeb, Oman
2Department of Family Medicine and Public Health, Sultan Qaboos University (SQU), Muscat, Oman

Received 16 August 2015; Revised 27 October 2015; Accepted 24 November 2015

Academic Editor: Bernard Venn

Copyright © 2015 Sanaa Al-Sumry et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, IDF Atlas Update, International Diabetes Federation, 6th edition, 2014.
  2. Diabetes Mellitus Management Guidelines, Ministry of Health, Muscat, Sultanate of Oman, 3rd edition, 2015.
  3. R. C. Silva, “Importância da avaliação da função tireoidiana em pacientes com diabetes mellitus,” Arquivos Brasileiros de Endocrinologia & Metabologia, vol. 49, no. 2, pp. 180–182, 2005. View at Publisher · View at Google Scholar
  4. G. E. Umpierrez, K. A. Latif, M. B. Murphy et al., “Thyroid dysfunction in patients with type 1 diabetes,” Diabetes Care, vol. 26, no. 4, pp. 1181–1185, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway, “The colorado thyroid disease prevalence study,” Archives of Internal Medicine, vol. 160, no. 4, pp. 526–534, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. G. Hollowell, N. W. Staehling, W. Dana Flanders et al., “Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III),” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 489–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Papazafiropoulou, A. Sotiropoulos, A. Kokoloki, M. Kardara, and P. Stamataki, “e Pappas S: prevalence of thyroid dysfunction among greek type 2 diabetic patients attending an outpatient clinic,” Journal of Clinical Medicine Research, vol. 2, no. 2, pp. 75–78, 2010. View at Google Scholar
  8. H. Gharib, R. M. Tuttle, J. Baskim, L. H. Fish, P. A. Singer, and M. T. McDermott, “Consensus statement. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association and the Endocrine Society,” Endocrine Practice, vol. 10, no. 6, pp. 497–501, 2004. View at Google Scholar
  9. J. L. Johnson, “Diabetes control in thyroid disease,” Diabetes Spectrum, vol. 19, no. 3, pp. 148–153, 2006. View at Google Scholar
  10. R. Kadiyala, R. Peter, and O. E. Okosieme, “Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies,” International Journal of Clinical Practice, vol. 64, no. 8, pp. 1130–1139, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. A.-R. M. Radaideh, M. K. Nusier, F. L. Amari et al., “Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan,” Saudi Medical Journal, vol. 25, no. 8, pp. 1046–1050, 2004. View at Google Scholar · View at Scopus
  12. D. H. Akbar, M. M. Ahmed, and J. Al-Mughales, “Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics,” Acta Diabetologica, vol. 43, no. 1, pp. 14–18, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Al-Geffari, N. A. Ahmad, A. H. Al-Sharqawi, A. M. Youssef, D. Alnaqeb, and K. Al-Rubeaan, “Risk factors for thyroid dysfunction among type 2 diabetic patients in a highly diabetes mellitus prevalent society,” International Journal of Endocrinology, vol. 2013, Article ID 417920, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Suzuki, M. Nanno, R. Gemma, I. Tanaka, T. Taminato, and T. Yoshimi, “The mechanism of thyroid hormone abnormalities in patients with diabetes mellitus,” Nippon Naibunpi Gakkai zasshi, vol. 70, no. 4, pp. 465–470, 1994. View at Google Scholar · View at Scopus
  15. P. Perros, R. J. McCrimmon, G. Shaw, and B. M. Frier, “Frequency of thyroid dysfunction in diabetic patients: value of annual screening,” Diabetic Medicine, vol. 12, no. 7, pp. 622–627, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Stanická, K. Vondra, T. Pelikánová, P. Vlček, M. Hill, and V. Zamrazil, “Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy,” Clinical Chemistry and Laboratory Medicine, vol. 43, no. 7, pp. 715–720, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Mitrou, S. A. Raptis, and G. Dimitriadis, “Insulin action in hyperthyroidism: a focus on muscle and adipose tissue,” Endocrine Reviews, vol. 31, no. 5, pp. 663–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. US Preventive Services Task Force, “Screening for thyroid disease: recommendation statement,” Annals of Internal Medicine, vol. 140, no. 2, pp. 125–127, 2004. View at Publisher · View at Google Scholar
  19. E. Güney, B. Efe, A. Akalın, M. N. Kebapçı, and E. Erenoğlu, “Thyroid disease in diabetes mellitus,” Turkish Journal of Endocrinology and Metabolism, vol. 3, pp. 119–122, 1999. View at Google Scholar
  20. R. W. Holl, B. Böhm, U. Loos, M. Grabert, E. Heinze, and J. Homoki, “Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus,” Hormone Research, vol. 52, no. 3, pp. 113–118, 1999. View at Publisher · View at Google Scholar · View at Scopus